Idiomas disponibles
Idiomas disponibles
4 I M P O R TA N T I N F O R M AT I O N
When observing the Instructions for Use and with a vaporization temperature
of 210°C (410°F) the following exemplary reference values are validated for
hemp flowers with a cannabinoid content of e.g. 19% THC and 0% CBD:
Amount of
hemp flowers
(Dosing Cap-
sule content)
50 mg
100 mg
150 mg
Reference values for hemp flowers with a cannabinoid content of e.g. 6% THC
and 7.5% CBD:
Amount of
hemp flow-
ers (Dosing
Capsule
content)
THC: 3 mg
50 mg
CBD: approx. 3.2 mg
THC: 6 mg
100 mg
CBD: approx. 7.5 mg
THC: 9 mg
150 mg
CBD: approx. 11 mg
In order to reach these values, inhalation must be continued until there is no
aerosol (vapor) recognizable when exhaling. The Dosing Capsule's content
is then depleted.
X If you have any questions about the medical use of cannabinoids or can-
nabis, contact your doctor, pharmacist or the manufacturers of medical
hemp flowers (Cannabis flos).
X You can find more information about cannabinoids on our homepage:
www.vapormed.com.
A B O U T C A N N A B I N O I D
Cannabinoid
content of the
hemp flower
portion
THC: 9.5 mg
THC: 19 mg
THC: 28.5 mg
Cannabinoid
content of the
hemp flower
portion
Cannabinoid
content in
the aerosol
(vapor)
approx. 5 mg
approx. 9.5 mg
approx. 14 mg
Cannabinoid
content in
the aerosol
(vapor)
approx. 1.5 mg
approx. 1.6 mg
approx. 3 mg
approx. 3.7 mg
approx. 4.5 mg
approx. 5.5 mg
59
Cannabinoid
content in blood
stream (systemic
bioavailability)
after inhalation
approx. 3 mg
approx. 6 mg
approx. 9.5 mg
Cannabinoid
content in blood
stream (systemic
bioavailability)
after inhalation
approx. 1 mg
approx. 1.1 mg
approx. 2 mg
approx. 2.3 mg
approx. 3 mg
approx. 3.5 mg
